Stichting Astma Bestrijding, The Netherlands Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2005
NCT00122694
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

carbon monoxide (1 trial)

Drugs in Other Trials (1)

beclomethasone (vanceril) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Inflammation (Phase 2)

Lung Diseases (Phase 2)

Pulmonary Disease, Chronic Obstructive (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2